1Reiner Z, Catapano AL, De Backer G, el al. ESC/EAS C-uidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology ( ESC ) and the European Atherosclerosis Society (EAS)[J].Eur Heart J, 2011,32 (14):1769- 1818. 被引量：1
2Lanrbert G. Unravelling the functional significance of PCSK9.[J].Curr Opin Lipidolol, 2007,18 (3) : 304-309. 被引量：1
4Qian Y, Schmidt R J, Zhang Y, et al. Secreted PCSK9 downregulates low density lipoprotein receptor through receptor mediated endocytosis[J]. J Lipid Res, 2007,48(7): 1488- 1498. 被引量：1
5Steinberg D, Witztum JI: Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levels[J]. Proc Natl Acad Sci U S A, 2009,106(24):9546-9547. 被引量：1
6Goldstein JL, Brown MS. The LDL receptor[J]. Arterioscler Thromb Vasc Biol, 2009,29(4) :431-438. 被引量：1
7Abifadel M, Rabes JP, Devillers M, et al. Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSKg) gene in cholesterol metabolism and disease[J].Hum Mutat, 2009,30(4) :520-529. 被引量：1
8Le May C, Kourimate S, Langhi C, et al. Proprotein convertase subtilisin kexin type 9 null mice are protected from postprandial triglyceridemia[J]. Arterioscler Thromb Vasc Biol, 2009,29(5) :684-690. 被引量：1
9Dubuc G, Chamberland A, Wassef H, et al. Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia [J]. Arterioscler Thromb Vasc Biol, 2004,24(8) : 1454-1459. 被引量：1
10Zhang D, Lagace TA, Garuti R, et al. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation[J]. J Biol Chem, 2007,282(25) :18602 -18612. 被引量：1
5Alonso R, Mata N, Castillo S, et al.Cardiovascular disease in familial hypercholesterolaemia :influence of low-density lipoprotein receptor mutation type and classic risk factors[J].Atherosclerosis, 2008,200 (2) :315-21. 被引量：1
6Vellore, Tamil Nadu.Familial hypercholesterolemia :A review[A]. Ann Pediatr Cardiol, 2014, 7 ( 2 ):107-17. 被引量：1
8Gray J, Jaiyeola A, Whiting M, et al.Identifying patients with familial hypercholesterolaemia in primary care :an informatics- based approach in one primary care centre[J].Heart, 2008,94 (6) : 754-8. 被引量：1
9lim~ni A, Harira Y,Trabelsi I, et al. Effect of E670G poly- morphism in PCSK9 gene on the risk and severity of coro- nary heart disease and ischemic stroke in a Tunisian co- hort [J]. J nol Neurosci,2014,53(2): 150-157. 被引量：1
10Tarasov K,Ekroos K, Suoniemi M,et al. Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9deficiency [J]. J Clin Endocrinol Metab, 2014,99 ( 1 ) : E45-52. 被引量：1
